Our team

Board of Directors

Christian Homsy
Chairman of the Board
Independent & Non-Executive Director

Christian Homsy

Chairman of the Board
Independent & Non-Executive Director

 

Jacques Galloy
Chairman of the Audit Committee
Independent & Non-Executive Director

Jacques Galloy

Chairman of the Audit Committee
Independent & Non-Executive Director

 

Inge Beernaert
Chairman of the Compensation and Nomination Committee
Independent & Non-Executive Director

Inge Beernaert

Chairman of the Compensation and Nomination Committee
Independent & Non-Executive Director

 

Jean-Michel Foidart
Executive Director

Jean-Michel Foidart

Executive Director

Professor Jean-Michel Foidart graduated in Gynecology from the University of Liège and also obtained a PhD in cell biology and biochemistry, before directing its Department of Gynecology-Obstetrics.

Co-founder of Mithra, he is the author of more than 1300 publications on women’s health and experimental oncology. Professor Foidart holds the Francqui Chair, Doctor Honoris Causa of the Pierre and Marie Curie University of Paris and the Paul Sabatier University of Toulouse. He is Officer of the Order of Leopold II, Commander, Grand Officer of the Order of the Crown, Professor Extraordinary, Honorary of the ULg and Perpetual Secretary of the Royal Academy of Medicine of Belgium. He was also General Secretary of the European Society of Gynecology and member of multiple editorial boards of international peer-reviewed journals.

Sidney Bens
Independent & Non-Executive Director

Sidney Bens

Independent & Non-Executive Director

 

Valérie Gordenne
Non-Executive Director

Valérie Gordenne

Non-Executive Director

Ms. Valérie Gordenne holds a Master's degree in Pharmacy from the University of Liège.

She has over 20 years of experience in pharmaceutical Research & Development with extensive leadership experience in full drug development across a range of therapeutic areas, in particular in women's health (CSO Mithra, CEO Novalon, General Manager Odyssea). Through the management of various functions and activities, she has developed a deep operational and strategic knowledge and expertise in drug development. She is currently Chief Scientific Officer at Auxin Surgery, CEO of the start-up Odix and advisor in regulatory affairs.

Key contacts

Fanny Rozenberg

Secretary of the Board

Fanny Storms

Compliance Officer